Metastatic Tumor Research and Outcomes Network
Metastatic Spine TumorThe registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* Patient 18 or older.
* Patient diagnosed with a metastatic tumor of the spine
* Informed consent obtained, i.e.:
* Ability to understand the content of the patient information/ICF
* Willingness and ability to participate in the registry according to the Registry Plan
* Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site)
Exclusion Criteria:
• Patient diagnosed with a primary tumor of the spine.
Study Location
Vancouver General Hospital and the University of British Columbia
Vancouver General Hospital and the University of British ColumbiaVancouver, British Columbia
Canada
Contact Study Team
McGill University Health Centre
McGill University Health CentreMontréal, Quebec
Canada
Contact Study Team
University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter
University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences CcenterToronto, Ontario
Canada
Contact Study Team
Winnipeg Spine Program University of Manitoba Department of Surgery
Winnipeg Spine Program University of Manitoba Department of SurgeryWinnipeg, Manitoba
Canada
Contact Study Team
Toronto Western Hospital Department of Neurosurgery Division of Surgery
Toronto Western Hospital Department of Neurosurgery Division of SurgeryToronto, Ontario
Canada
Contact Study Team
- Study Sponsored By
- AO Innovation Translation Center
- Participants Required
- More Information
- Study ID:
NCT02830451